CVC Capital and Mehiläinen Complete Landmark Acquisitions of Regina Maria and MediGroup in Southeast Europe

We are pleased to announce the successful completion of the acquisitions of Regina Maria, Romania’s leading private healthcare network, and MediGroup, Serbia’s premier private healthcare provider, by CVC Capital Partners and Mehiläinen.

BOPA had the privilege of advising CVC Capital and Mehiläinen, alongside a consortium of top-tier international advisors, on the acquisition of MediGroup in Serbia. Transactions were executed under the strategic leadership of Mehiläinen and in close coordination with leading global law firms and financial advisors. Following the receipt of all requisite regulatory approvals, the transactions were completed seamlessly, marking a significant milestone in Mehiläinen’s European growth strategy.

Throughout this complex, multi-jurisdictional process, BOPA worked together with other leading international law firms to guide the client through each phase of the transaction, ensuring a smooth closing and the successful integration of this flagship healthcare platform.

The transactions also welcomed Hellman & Friedman as a second cornerstone investor in Mehiläinen, joining CVC Capital alongside management, employees, private investors, and Finnish institutional investors - further reinforcing Mehiläinen’s long-term strategic vision.

About the healthcare networks

1)     Regina Maria serves more than two million patients annually and is widely recognized for its clinical excellence, internationally accredited hospitals, and strong commitment to healthcare digitalization.

2)    MediGroup is Serbia’s leading private healthcare system, operating a nationwide network of healthcare centers, hospitals, and diagnostic facilities, supported by more than 2,500 medical professionals delivering comprehensive, high-quality care.

Together, these acquisitions further solidify Mehiläinen’s position as a leading, integrated, outpatient-focused healthcare provider in Europe. The group now operates over 1,500 locations across seven countries, serving more than five million patients each year.

BOPA is proud to be at the centre of these transformative healthcare transactions, supporting clients in the execution of ambitious cross-border strategies and long-term growth objectives.

We extend our sincere thanks to all counterparties who contributed to this landmark transaction, which also represents the largest Finnish investment in Serbian history. The Serbian aspects of the transaction were led by BOPA partners Vladimir Bojanović, Ivan Štrbac, Nikola Gvoić, and Jelena Obradović.

For details, please see official press release.